PERSPECTA

News from every angle

← Back to headlines

Johnson & Johnson Acquires Firefly Bio for $1 Billion

Johnson & Johnson has announced its acquisition of Firefly Bio, a company specializing in cancer drug technology development, for $1 billion in cash. This strategic move aims to bolster J&J's oncology pipeline.

8 Jun, 13:33 — 8 Jun, 13:33
PostShare

Sources

Showing 1 of 3 sources
YahooMostly Factual79d ago

Johnson & Johnson acquires Firefly Bio for $1 billion

Read full article →

Coverage Timeline

First report: seeking-alpha · 8 Jun, 12:42Full coverage: 3 · 51mWindow: 51m
Left-leaningCenterRight-leaning
seeking-alpha8 Jun, 12:42First to report

Johnson & Johnson to buy Firefly Bio for $1B in cash

naftemporiki8 Jun, 12:48

Η Johnson & Johnson εξαγοράζει την Firefly Bio, εταιρεία ανάπτυξης τεχνολογίας φαρμάκων για τον καρκίνο, έναντι 1 δισεκ. δολαρίων

Yahoo8 Jun, 13:33Latest update

Johnson & Johnson acquires Firefly Bio for $1 billion

Related Stories

Abercrombie & Fitch Shares Surge on Strong Second-Quarter Earnings and Raised Guidance

24m ago

TWG Global Denies Fraud Allegations and Lakers Fire Sale Rumors Amid Federal Probe

28m ago

Analysts Downgrade Qifu Technology and Lower Intuit Price Targets on Sector Headwinds

31m ago

Two Airport Staff Die of Malaria at Frankfurt Airport

37m ago